4.5 Article

Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease

Journal

NEUROBIOLOGY OF AGING
Volume 35, Issue 12, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2014.06.002

Keywords

Alzheimer's disease; Neurodegenerative dementia; APP; PSEN1; PSEN2; MAPT; GRN; PRNP; Exome sequencing

Funding

  1. Alzheimer's Research UK
  2. Medical Research Council (MRC)
  3. Wellcome Trust/MRC Joint Call in Neurodegeneration Award [WT089698]
  4. National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London
  5. National Institute on Aging [ZO1 AG000950-10]
  6. National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services) [ZO1 AG000950-10]
  7. Alzheimer's Association
  8. [P50 AG016574]
  9. [U01 AG006786]
  10. [R01 AG18023]
  11. Alzheimers Research UK [ARUK-TRFUS2012-3, ART-BIG2009-1, ARUK-NCG2012B-1, ARUK-NCG2014A-1, ARUK-PG2014-2, ARUK-TRFUS2012-1] Funding Source: researchfish
  12. Medical Research Council [G1100695, MC_G1000735] Funding Source: researchfish
  13. MRC [G1100695, MC_G1000735] Funding Source: UKRI

Ask authors/readers for more resources

The overlapping clinical and neuropathologic features between late-onset apparently sporadic Alzheimer's disease (LOAD), familial Alzheimer's disease (FAD), and other neurodegenerative dementias (frontotemporal dementia, corticobasal degeneration, progressive supranuclear palsy, and Creutzfeldt-Jakob disease) raise the question of whether shared genetic risk factors may explain the similar phenotype among these disparate disorders. To investigate this intriguing hypothesis, we analyzed rare coding variability in 6 Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP), in 141 LOAD patients and 179 elderly controls, neuropathologically proven, from the UK. In our cohort, 14 LOAD cases (10%) and 11 controls (6%) carry at least 1 rare variant in the genes studied. We report a novel variant in PSEN1 (p.I168T) and a rare variant in PSEN2 (p.A237V), absent in controls and both likely pathogenic. Our findings support previous studies, suggesting that (1) rare coding variability in PSEN1 and PSEN2 may influence the susceptibility for LOAD and (2) GRN, MAPT, and PRNP are not major contributors to LOAD. Thus, genetic screening is pivotal for the clinical differential diagnosis of these neurodegenerative dementias. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available